Physician Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Physician Wealth Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.92K	Sell	23 -1	-4%	-$302	﹤0.01%	982
2026 Q1	$7.94K	Hold	24	–	–	﹤0.01%	865
2025 Q4	$9.54K	Sell	24 -7	-23%	-$3.1K	﹤0.01%	781
2025 Q3	$14.1K	Buy	+31	New	+$12.6K	﹤0.01%	656

Other funds holding ALNY

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SSA

Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

PSC

Portman Square Capital London, United Kingdom $2.11B AUM 19.71% 1-Year Est. Return

Physician Wealth Advisors's ALNY Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Alnylam Pharmaceuticals (ALNY) stake by 4.2% in Q2 2026, selling an estimated $302 and leaving 23 shares worth $6.92K. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Physician Wealth Advisors first reported a position in ALNY in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.1K in Q3 2025. 118 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Physician Wealth Advisors held 23 shares of Alnylam Pharmaceuticals worth $6.92K as of Q2 2026.
Physician Wealth Advisors sold 1 Alnylam Pharmaceuticals share in Q2 2026, an estimated $302.
Alnylam Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #982 holding.
Physician Wealth Advisors first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
Physician Wealth Advisors's Alnylam Pharmaceuticals position peaked at $14.1K in Q3 2025.
118 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.